88 Economic evaluation of a cluster randomized trial for an accelerated, high-sensitivity cardiac troponin protocol
Recommended Citation
Hawatian K, Danagoulian S, Nassereddine H, Morton TJ, Cook B, Klausner HA, Gunaga S, Levy P, Mahler SA, Krupp SS, McCord J, Miller J. 88 Economic evaluation of a cluster randomized trial for an accelerated, high-sensitivity cardiac troponin protocol. Acad Emerg Med 2024; 31(S1):48.
Document Type
Conference Proceeding
Publication Date
5-13-2024
Publication Title
Acad Emerg Med
Abstract
Background and Objectives: Accelerated protocols (AP) using high-sensitivity cardiac troponin (hs-cTn) to evaluate for myocardial infarction (MI) are becoming increasingly common in the United States (US), but their cost effectiveness remains unknown in the US. Added sensitivity within such protocols could drive costs higher. We aimed to measure the implementation of a hs-cTn AP compared to a conventional protocol on overall treatment cost and length of stay. Methods: We performed a planned secondary economic analysis of a large, cluster randomized trial across 9 emergency departments (EDs) from July 2020 to April 2021. Patients 18?years or older with clinical suspicion for MI were included and we excluded those with ST-segment MI or traumatic chest pain. According to the AP, patients could be discharged without further testing at 0?h if they had a hs-cTnI?
Volume
31
Issue
S1
First Page
48
